outbreak, there have been several experimental infection studies conducted on pigs, using pH1N1 human isolates (5) (6) (7) (8) . These experiments showed that the clinical signs were similar to those observed in classical swine influenza virus (SIV)-infected pigs. As SIV is related to respiratory diseases in pigs (9) (10) (11) , farmers and practitioners have used SIV vaccines for disease control. In Korea, commercialized vaccines contain SIV H1N1, H3N2, and H1N2 strains that had been isolated before 2009. The objectives of this study were (i) to characterize the genome of a SIV H1N1 strain isolated from a Korean pig farm and (ii) to demonstrate the potential of the isolated strain as a vaccine candidate.
Materials and MethOds
isolation and sequence analysis of the swine influenza a (h1n1) virus As part of the monitoring for pH1N1 after its first outbreak in Korean pig farms in December 2009, specimens from a breeding farm with about 6000 pigs were tested using real-time RT-PCR primers specific to pH1N1 (Bionote, Hwasung, Korea). Although the results were positive for all specimens tested, interestingly the pigs did not show prominent respiratory syndrome. The farm was also known to be virologically negative for porcine reproductive and respiratory syndrome. Virus isolation was attempted from the lung sample homogenates using Madin-Darby canine kidney (MDCK) cells and embryonated eggs.
The genome of the isolated pH1N1 virus was partially sequenced for the HA, NA, NP, NS, PA, PB1, and PB2 genes, and fully sequenced for the M gene using primers previously described (12) . The sequencing analysis to confirm the identity of the virus was performed commercially (Genotech, Daejeon, Korea). The sequences of the isolate were compared with those of other pH1N1 and classical swine (H1N1) virus strains, and phylogenetic trees were constructed for the HA and NA genes using the neighbor-joining method in the MEGA 4.0 program. inactivation of the virus and animal study A swine influenza vaccine was prepared with the inactivated virus. The SIV isolate, A/swine/GCVP-KS01/ 2010 (H1N1), serially passaged to a hemagglutination titer of 256 HAU/50 ml, was used as the antigen and mixed with aluminum hydroxide gel (Rehydragel ® ; Chemtrade, Toronto, ON, Canada) at an antigen-to-adjuvant ratio of 90:10 (v/v). Viruses were inactivated using 0.2% of 40% formalin for 24 hours in room temperature. This trial vaccine was administered to 24 heads of Guinea pigs (300~350 g body weight) and 6 heads of piglets (4 weeks old). All the animals were intramuscularly injected with 1 ml of the vaccine. At 2 weeks after vaccination, a booster injection was administered by the same method as the initial vaccination. For the safety test of the vaccine 
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in the animals, vaccinated animals were observed for 7 days and 14 days after vaccination in Guinea pigs and piglets, respectively. Any clinical signs related with systemic reaction including fever, anorexia, and death should not be observed in all of the vaccinated animals.
And local reaction such as irritation, redness, swelling, necrosis of the injection site should be observed. Before vaccination and at 2 weeks after the second vaccination, blood samples were drawn for serologic analysis by the hemagglutination inhibition (HI) test. Animal study complied with the current laws of South Korea. Animal care and treatment were conducted according to guidelines by the Green Cross Veterinary Products Institutional Animal Care and Use Committee (GCVP-IACUC). The approval number of this animal study was GCV-10-4-02.
results isolation and sequence analysis of the swine influenza a (h1n1) virus The virus was successfully isolated in the MDCK cell line only after a second passage, and was designated as A/swine/GCVP-KS01/2010 (H1N1) (GCVP-KS01). Partial sequences of eight gene segments from GCVP-KS01 showed 98.9% to 99.9% similarity to those of the A/California/04/2009 strain and other pH1N1 isolates from humans and pigs (Table I ). The HA, NA, M, NS, NP, and PA nucleotide sequences of GCVP-KS01 showed 99%, 99.3%, 99.6%, 99.1%, 99.1%, and 99.5% similarity to the respective sequences of the A/California/04/2009 strain. Interestingly, the HA gene of the pH1N1 virus isolated from humans in Korea was closely related to that of GCVP-KS01 (Fig. 1) . A previously reported pH1N1 strain isolated from pigs, A/swine/Korea/SCJ01/2009 (H1N1), also had close sequence similarity to GCVP- 
immunogenicity of the inactivated virus
The trial vaccine made from strain GCVP-KS01 resulted in seroconversion at 2 weeks after the second vaccination in all of the vaccinated animals. The geometric means of the HI titer were 380.5 (range: 160~640) and 403.2 (range: 320~640) for the Guinea pigs and piglets, respectively (Table II) . And all of the vaccinated animals did not present any clinical signs during observation period. And also, there were no local or systemic reaction after vaccination.
discussiOn
The SIV strain isolated from pigs in this study presented similar genetic characteristics as the pH1N1 viruses. A limitation of this study was that a complete sequence (13) . The changes in epidemiology of swine influenza after 2009 might suggest changes of the control methods, especially vaccines. As tested in this study, the SIV vaccine containing strain GCVP-KS01 resulted in seroconversion in the vaccinated animals. This strain can therefore be a potential vaccine candidate against pH1N1 or other SIVs that have genetic relationship with the HA gene of pH1N1. The protective efficacy of this vaccine should be investigated in pigs.
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